Key result
Brief CBT was superior to treatment as usual in reducing disease severity at 24 weeks in patients with noncardiac chest pain and comorbid panic or depressive disorders (P<.001).
Why the study?
Does brief cognitive behavioral therapy reduce disease severity in adults with noncardiac chest pain and comorbid panic and/or depressive disorders?
RCT (n=113)
Single-blind
No
Does brief cognitive behavioral therapy reduce disease severity in adults with noncardiac chest pain and comorbid panic and/or depressive disorders?
p-value: p=<.001
Brief cognitive behavioral therapy significantly reduces disease severity, anxiety, and depressive symptoms in patients with noncardiac chest pain and comorbid psychiatric disorders.
Supports brief CBT integration into care for noncardiac chest pain with psychiatric comorbidity; extends RCT evidence for psychological interventions in this population.
BACKGROUND: Most patients with noncardiac chest pain experience anxiety and depressive symptoms. Commonly they are reassured and referred back to primary care, leaving them undiagnosed and untreated. Some small studies have suggested efficacy of 12 cognitive behavioral therapy (CBT) sessions. Our aim was to examine efficacy of brief CBT in reducing anxiety and depressive symptoms in patients with noncardiac chest pain and comorbid panic and/or depressive disorders. METHODS: In this 24-week randomized controlled trial comparing CBT (n = 60) versus treatment as usual (TAU, n = 53), we included all adults who presented at the cardiac emergency unit of a university hospital with noncardiac chest pain, scored ≥8 on the hospital anxiety and depression scale (HADS) and were diagnosed with a comorbid panic and/or depressive disorder with the Mini International Neuropsychiatric Interview. CBT consisted of six individual sessions. Main outcome was disease severity assessed with the clinical global inventory (CGI) by a blinded independent rater. RESULTS: ANCOVA in the intention-to-treat and completer sample showed that CBT was superior to TAU after 24 weeks in reducing disease severity assessed with CGI (P < .001). Secondary outcomes on anxiety (HADS-anxiety, state trait anxiety inventory (STAI)-trait) and depressive symptoms (Hamilton depression rating scale) were in line with these results except for HADS-depression (P = .10), fear questionnaire (P = .13), and STAI-state (P = .11). CONCLUSIONS: Brief CBT significantly reduces anxiety and depressive symptoms in patients with noncardiac chest pain who are diagnosed with panic and/or depressive disorders. Patients presenting with noncardiac chest pain should be screened for psychopathology and if positive, CBT should be considered.
No takes yet. Share an insight, caveat, or question.
Beek et al. (2013) conducted an RCT in Noncardiac chest pain with comorbid panic and/or depressive disorder (n=113). Brief cognitive behavioral therapy (CBT) vs. Treatment as usual (TAU) was evaluated on Disease severity assessed with the clinical global inventory (CGI) (p=<.001). Brief CBT was superior to treatment as usual in reducing disease severity at 24 weeks in patients with noncardiac chest pain and comorbid panic or depressive disorders (P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: